Multimodal treatment approaches for peritoneal carcinosis in colorectal cancer.
Abstract
15% to 20% of patients with metastatic colorectal cancer show isolated peritoneal carcinomatosis with significat clinical relevance. Their prognosis is poor, with a reported mean survival of less than one year. Moreover, there is a lack of knowledge regarding treatment optimally tailored to individual patients.
Bibliographical data
| Original language | English |
|---|---|
| Article number | 47 |
| ISSN | 1866-0452 |
| Publication status | Published - 2011 |
| pubmed | 22190994 |
|---|
